PubMed Health⌕ Search

Biomedical subjects

J Harle

Publications and source records attributed to J Harle.

9 recordsLinked to original sources
PubMed2001

Effects of ultrasound on the growth and function of bone and periodontal ligament cells in vitro.

The effects of therapeutic ultrasound (US) on tissue healing processes in vivo are likely to involve US-induced changes in key cellular functions. However, these have not yet been clearly delineated and the present study has, therefore, examined the effects of a single 5-min CW exposure of 3.00-MHz US on the growth and functional activity of a human osteoblast-like cell line (MG63 cells) and human periodontal ligament (PDL) cells in vitro. Although cell proliferation was found to be largely unaffected by spatial average intensity (I(SA)) values of between 140-990 mW/cm(2), flow cytometry (FCM) analysis showed that there were pronounced and differential effects on cell function. Thus, bone-associated proteins were down-regulated, whereas collagen type I (COL I) was unaffected and fibronectin (FN) was up-regulated at low intensities in MG63 cells. In contrast, bone protein expression was found to be dose-dependent, and FN and COL I were down-regulated in PDL cells. These results show that US has potentially important effects on the functional activities of connective tissue cells in vitro, which could markedly influence tissue repair and regeneration processes in vivo.

Cell Division↗
PubMed2000

Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditions.

OBJECTIVE: To assess the efficacy, tolerability, and safety of riluzole in the treatment of peripheral neuropathic pain conditions. BACKGROUND: Both basic and clinical research has demonstrated that drugs with sodium channel and NMDA antagonism can be effective in alleviating neuropathic pain. Riluzole, a drug currently used for treatment of ALS, possesses these properties. It was hypothesized that riluzole would be effective in reducing the pain in subjects with peripheral neuropathic pain. METHODS: Two randomized, placebo-controlled, crossover studies were performed at two sites. Study 1 compared 100 mg/day of riluzole (the currently recommended dosage for treatment of ALS) versus placebo, and Study 2 compared 200 mg/day of riluzole versus placebo. Each treatment phase (both studies) was 2 weeks long, separated by 2-week wash-out periods. Outcome measures included change in the score on a 100-mm pain intensity visual analog scale, the Neuropathic Pain Scale, allodynia, hyperalgesia, and preference for study treatment phase. RESULTS: Twenty-two subjects completed Study 1, and 21 subjects completed Study 2. Four subjects (two from each study) discontinued the study because of intolerable side effects. No statistical difference was found for any study outcome measure between riluzole and placebo for either study. In Study 1, pain intensity was more likely to increase than decrease with riluzole (mean treatment difference 8.7 mm; 95% CI -19.5 to +2.1 mm). In Study 2, very slight pain reduction was observed with riluzole compared with placebo (mean treatment difference 1.4 mm; 95% CI -5.1 to +8.0 mm). In both studies, the majority of subjects chose "no change" in pain on the category relief scale after placebo and riluzole treatment phases. On study completion, no treatment preference was reported by 76% of the subjects in Study 1 and by 61% of the subjects in Study 2. CONCLUSIONS: Doses of riluzole at (100 mg) or above (200 mg) those used for the treatment of ALS were not effective in alleviating peripheral neuropathic pain.

Adult↗
PubMed1996

Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study.

The local anesthetic sodium-channel blockers lidocaine and mexiletine reduce spontaneous and evoked activity in experimental neuroma models and have been reported to relieve a variety of clinical neuropathic pain conditions. The predictive value of relief from an intravenous lidocaine infusion (IVL) for subsequent relief from a 4-week trial of oral mexiletine was assessed in a prospective study of nine subjects with chronic neuropathic pain of peripheral origin. Subjects received IVL, 2 mg/kg and 5 mg/kg, over 45 min during separate sessions in random order under double-blind conditions. One week later, a 4-week titrating trial of oral mexiletine was initiated. Both doses of IVL significantly reduced pain visual analogue scores (VAS) scores. Although IVL 5 mg/kg produced significantly higher pain relief scores than IVL 2 mg/kg, subjects responded in a highly consistent manner to the two IVL. Subsequent response to oral mexiletine was significantly correlated with the average response to the two IVL. Mexiletine dose and blood levels were not correlated with pain relief. The results suggest that IVL may be a valuable tool in selecting patients for oral therapy with analogous drugs.

Administration, Oral↗
PubMed1981

[Prognostic value of bad distal irrigation incides, revealed by irrigraphy in arteritis of the lower limbs (author's transl)].

A study is made in this paper of the prognostic significance of a very low distal index (index 6), revealed by irrigraphy. On the basis of examination of 55 case histories, the patients were divided into two groups A and B as a function of the distal indices at the root of the limb. The amputation rate was very high in both groups, but the prognosis was better in group A where the situation could be improved by restorative surgery at a high level. Analysis of the surgical possibilities has indicated that restorative surgery at a high level is a promising procedure, especially in group A. Surgery at the femoro-popliteal level yielded less satisfactory results because of the often considerable degradation of the arterial bed further downstream. Sympathectomy appears to be a useful supplement to restorative surgery in appropriate cases. The concept of the reduced distal index is also valuable for detecting cases of arteritis which are still well compensated but are in danger of vascular failure (dangerous claudications).

Arteries↗
PubMedDate not supplied

The mechanisms of venous stasis in post-phlebitic syndromes.

Venous stasis in post-phlebitic syndromes may be caused by several physiopathological processes. Phlebography and functional investigations (Doppler, occlusive rheoplethysmography) enables us to make a fairly precise analysis of the causal factors: --The obstruction of a large venous collector defines the obstructive syndromes. The size of the stasis depends on the functional value of the substitutional channels; distinction may be made between compensated obstructive syndromes (with efficient substitutional circulation) and poorly or non-compensated obstructive syndromes. --Orthostatic reflux in devalvulated deep veins constitutes another factor of stasis. Distinction to be made between minor reflux, and major reflux with massive reflux in the great trunks and associated insufficiency of the tibial communicators. --Post-phlebitic superficial venous insufficiency is often observed. Its physiopathology is basically no different to that of primary varices, the functioning of the tibial communicators is often perturbed. --The restrictive syndrome, result of functional investigations, corresponds to a reduction of the venous distensibility whose effects are superadded to those of the syndromes described above.

Blood Flow Velocity↗
PubMedDate not supplied

[Value of rheoplethysmography with venous occlusion in the detection of venous thrombosis].

The study of the correlations between occlusive rheoplethysmography (RPO) and phlebography, carried out in 170 explorations, shows an over-all rate of 78.3% correct correlations. This correlations is more accurate for negative RPOs (91.8%) than for positive ones (59.6%). There are in fact few inaccurate negatives (i.e. venous thrombosis with negative RPO) but there are a certain number of erroneous positives, linked basically with states of cardiac insufficiency and phlebitic after-effects. The RPO examination is a useful complement to the clinical data; it means that the number of necessary phlebographical examinations can be cut down, and it provides a useful guide to treatment options.

Diagnosis, Differential↗
PubMedDate not supplied

[Study of venous distensibility using plethysmography with venous occlusion in post-phlebitic syndromes].

Venous distensibility has been studied in the cases of twelve patients presenting a post-phlebitic syndrome, compared with five patients with primary varicose veins. In the post-phlebitic syndromes we note far fewer symptoms of venous distensibility, whereas in the cases of varicose veins there is an increase of venous distensibility. Statistics of the delta V max. 50 and the symptoms of distensibility are given in a recapitulatory table, and a diagram.

Humans↗
PubMedDate not supplied

[The clinical problem of false phlebitis].

This is a study of some of the problems presented by "false phlebitis". This problem arises when patients are wrongly considered as post-phlebitis when the venous system is intact. There is also the problem of false diagnoses of venous thrombosis leading to anticoagulant treatment which is not indicated or to surgical measures, equally unjustified for the prevention of possible pulmonary embolism. Finally there is the problem of venous compression simulating thrombosis where the diagnosis of thrombosis leads to delay in the institution of specific treatment. The current means of diagnosis, phlebography and functional investigations, should permit a significant reduction in the number of these errors of diagnosis which may be of great disadvantage to the patients.

Diagnostic Errors↗